featured
Outcomes of Intravenous vs Subcutaneous Trastuzumab in Patients With HER2+ Metastatic Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Breast Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Long Terms Follow-Up of the Randomized MetaspHER Study Comparing Intravenous Versus Subcutaneous Trastuzumab in Patients' With HER2-Positive Metastatic Breast Cancer
Clin. Breast Cancer 2023 Jun 20;[EPub Ahead of Print], X Pivot, JP Spano, M Espie, C Jouannaud, V Pottier, L Moreau, JM Extra, A Lortholary, P Rivera, D Spaeth, Z Mouri, F Tariket, J Dupin, A Berthois, M Ionescu-Goga, A Ferhat, P Cottu, J GligorovFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.